Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Bristol-Myers Squibb announces Spanish launch of antiplatelet drug

March 25, 1999

ACS highlights: 3-D progresses in development of new class of thrombin inhibitors

March 24, 1999

Texas Biotechnology resubmits Novastan NDA

March 24, 1999

Another anticoagulant series presented by DuPont at the ACS meeting

March 23, 1999

ACS highlights: new noncovalent thrombin inhibitors described by Merck & Co.

March 23, 1999

DuPont presents potent and selective factor Xa inhibitors

March 23, 1999

Japan is country of first launch for Yamanouchi's second-generation t-PA

March 23, 1999

Profile of CS-747, a novel antiplatelet agent from Sankyo and Ube

March 22, 1999

First clinical experiences reported with S-1197 and its orally active prodrugs

March 22, 1999

Preliminary InTIME-II results point to equivalence of lanoteplase and alteplase in AMI

March 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...